Ellen Hukkelhoven serves as the Head of Investment Research for Perceptive Advisors. At Perceptive, she focuses on public and private development stage therapeutic companies. Ellen also serves on the boards of MeiraGTx, Freenome, Kindbody and Partner Therapeutics. Prior to joining Perceptive in 2013, Ellen received her PhD in cancer biology from Memorial Sloan Kettering Cancer Center. During her tenure at MSKCC, she founded and built the life sciences division of InSITE, a top graduate fellowship program that helps early-stage companies with their most pressing needs. Ellen graduated magna cum laude from Princeton University with degrees in molecular biology and finance.